CTXR · Citius Pharmaceuticals, Inc.
$0.55
+0.07 (+13.51%)
At close · Jul 21
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The accompanying unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. We incurred a net loss of $37,503,635 for the six months ended March 31, 2026. The Company experienced negative cash flows from operations of $14,308,843 for the six months ended March 31, 2026. At March 31, 2026, the Company had $4,590,174 in cash and a negative working capital of approximately $23.3 million.”View the 10-Q filed May 15, 2026
Market Cap
$14.98M
Shares
27.45M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-01 | — | |
| 8-K | 2026-05-15 | — | |
| 10-Q | 2026-05-15 | 2026-03-31 | |
| 8-K | 2026-05-08 | 2026-05-04 | |
| 8-K | 2026-04-29 | 2026-04-23 | |
| 8-K | 2026-04-24 | 2026-04-23 | |
| 8-K | 2026-04-06 | — | |
| 8-K | 2026-03-31 | — | |
| 8-K | 2026-03-10 | — | |
| 8-K | 2026-03-04 | — | |
| DEF 14A | 2026-02-24 | 2026-04-06 | |
| 10-Q | 2026-02-13 | 2025-12-31 | |
| 8-K | 2026-02-13 | 2026-02-09 | |
| 10-K/A | 2026-01-28 | 2025-09-30 | |
| 8-K | 2025-12-23 | — | |
| 10-K | 2025-12-23 | 2025-09-30 | |
| 8-K | 2025-12-01 | — | |
| 8-K | 2025-10-23 | — | |
| 8-K | 2025-10-21 | 2025-10-20 | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-12 | — | |
| 8-K | 2025-07-08 | 2025-07-07 | |
| 8-K | 2025-06-12 | 2025-06-09 | |
| 8-K | 2025-06-09 | — | |
| 8-K | 2025-06-03 | 2025-06-02 | |
| 8-K | 2025-05-30 | 2025-05-29 | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 8-K | 2025-05-14 | — | |
| DEF 14A | 2025-04-28 | 2025-06-09 | |
| 8-K | 2025-04-18 | 2025-04-16 | |
| 8-K | 2025-04-03 | 2025-03-28 | |
| 8-K | 2025-04-02 | 2025-04-01 | |
| 8-K | 2025-03-10 | — | |
| 10-Q | 2025-02-14 | 2024-12-31 | |
| 8-K | 2025-02-14 | — | |
| 8-K | 2025-02-06 | — | |
| 10-K/A | 2025-01-27 | 2024-09-30 | |
| DEF 14A | 2025-01-27 | 2025-03-10 | |
| 8-K | 2025-01-08 | 2025-01-07 | |
| 8-K | 2025-01-07 | — | |
| 10-K | 2024-12-27 | 2024-09-30 | |
| 8-K | 2024-12-27 | — | |
| 8-K | 2024-12-20 | 2024-12-18 | |
| 8-K | 2024-11-26 | 2024-11-25 | |
| 8-K | 2024-11-25 | — | |
| 8-K | 2024-11-18 | 2024-11-15 | |
| 8-K | 2024-11-13 | 2024-11-06 | |
| 8-K | 2024-11-12 | 2024-11-11 | |
| 8-K | 2024-09-27 | 2024-09-25 | |
| 8-K | 2024-09-13 | 2024-09-09 |
Showing 1–50 of 168 filings